Physician Wealth Advisors Inc. Grows Position in Oracle Co. (NYSE:ORCL)

Physician Wealth Advisors Inc. boosted its holdings in Oracle Co. (NYSE:ORCL) by 17.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,946 shares of the enterprise software provider’s stock after buying an additional 283 shares during the quarter. Physician Wealth Advisors Inc.’s holdings in Oracle were worth $324,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Principal Financial Group Inc. grew its position in Oracle by 5.3% in the 3rd quarter. Principal Financial Group Inc. now owns 2,416,362 shares of the enterprise software provider’s stock worth $411,748,000 after purchasing an additional 121,874 shares during the period. McClarren Financial Advisors Inc. grew its holdings in shares of Oracle by 201.7% in the fourth quarter. McClarren Financial Advisors Inc. now owns 1,599 shares of the enterprise software provider’s stock worth $266,000 after acquiring an additional 1,069 shares during the period. RMR Wealth Builders grew its holdings in shares of Oracle by 383.4% in the fourth quarter. RMR Wealth Builders now owns 7,155 shares of the enterprise software provider’s stock worth $1,192,000 after acquiring an additional 5,675 shares during the period. Foundations Investment Advisors LLC increased its position in Oracle by 24.8% during the fourth quarter. Foundations Investment Advisors LLC now owns 164,593 shares of the enterprise software provider’s stock valued at $27,428,000 after acquiring an additional 32,718 shares during the last quarter. Finally, Crews Bank & Trust bought a new position in Oracle in the fourth quarter valued at about $1,800,000. Institutional investors own 42.44% of the company’s stock.

Wall Street Analysts Forecast Growth

ORCL has been the subject of several research reports. Barclays reduced their price target on shares of Oracle from $212.00 to $202.00 and set an “overweight” rating for the company in a research report on Tuesday, March 11th. DA Davidson restated a “neutral” rating and issued a $150.00 price objective on shares of Oracle in a research note on Tuesday, March 11th. Guggenheim reiterated a “buy” rating and set a $220.00 target price on shares of Oracle in a research report on Wednesday, March 5th. Jefferies Financial Group upped their price target on Oracle from $190.00 to $220.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $205.00 price objective on shares of Oracle in a research report on Wednesday, January 22nd. Thirteen analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Oracle presently has a consensus rating of “Moderate Buy” and a consensus target price of $179.20.

Oracle Stock Performance

NYSE ORCL opened at $140.75 on Friday. The business’s 50 day moving average price is $163.94 and its 200-day moving average price is $170.22. Oracle Co. has a fifty-two week low of $112.78 and a fifty-two week high of $198.31. The company has a market cap of $393.67 billion, a P/E ratio of 34.41, a P/E/G ratio of 3.46 and a beta of 1.07. The company has a debt-to-equity ratio of 5.65, a quick ratio of 0.81 and a current ratio of 0.81.

Oracle (NYSE:ORCL) last posted its quarterly earnings data on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts’ consensus estimates of $1.49 by ($0.02). The firm had revenue of $14.13 billion for the quarter, compared to the consensus estimate of $14.40 billion. Oracle had a net margin of 21.16% and a return on equity of 133.25%. The company’s revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.41 EPS. Sell-side analysts predict that Oracle Co. will post 5 earnings per share for the current year.

Oracle Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Thursday, April 10th will be paid a $0.50 dividend. The ex-dividend date is Thursday, April 10th. This represents a $2.00 annualized dividend and a yield of 1.42%. This is an increase from Oracle’s previous quarterly dividend of $0.40. Oracle’s dividend payout ratio (DPR) is presently 46.95%.

Insider Buying and Selling at Oracle

In other news, CEO Safra Catz sold 2,101,154 shares of the business’s stock in a transaction on Wednesday, January 22nd. The shares were sold at an average price of $185.35, for a total transaction of $389,448,893.90. Following the completion of the sale, the chief executive officer now directly owns 1,118,592 shares of the company’s stock, valued at approximately $207,331,027.20. The trade was a 65.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 42.20% of the company’s stock.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.